“As new Alzheimer’s drugs have failed, scientists are shifting focus to other potential causes,” by Berkeley Lovelace, Jr., NBC News
“As yet another Alzheimer’s drug targeting plaque buildup in the brain fails to improve cognition in patients, leading scientists said a significant shift is underway in the search for effective treatments for the disease. The new direction in Alzheimer’s research — away from focusing solely on beta-amyloid plaques to other potential causes, including brain inflammation and conditions related to diabetes — comes from growing evidence that multiple factors contribute to the development of the disease.”
LTC Comment, Stephen A. Moses, President, Center for Long-Term Care Reform:
“If at first you don’t succeed, try, try again” but doing the same thing over and over again is the definition of insanity. So, it’s about time science looks more closely at the idea of Alzheimer’s as “Type 3 Diabetes,” the result of unhealthy lifestyles.
Subscribe to GoldenCare News